Dr. Scagliotti on the Future of Multiple Gene Profiles

Giorgio V. Scagliotti, MD, PhD
Published: Wednesday, Oct 12, 2011

Giorgio V. Scagliotti, MD, PhD, head of the Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, believes that in the near future it will be possible to systematically investigate multiple genes to establish the full role of a pathway in the tumor.

The DNA repair protein ERCC1 is being describes as a paradigm for the entire DNA repair process, Scagliotti explains, however, that a single gene is not ample to mirror the entire DNA repair mechanism. Examining the full profile of several genes will provide better information about how to treat the patients properly and their cytotoxic profiles.

Giorgio V. Scagliotti, MD, PhD, head of the Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, believes that in the near future it will be possible to systematically investigate multiple genes to establish the full role of a pathway in the tumor.

The DNA repair protein ERCC1 is being describes as a paradigm for the entire DNA repair process, Scagliotti explains, however, that a single gene is not ample to mirror the entire DNA repair mechanism. Examining the full profile of several genes will provide better information about how to treat the patients properly and their cytotoxic profiles.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x